ArticleAntimicrobial agents and chemotherapy2019

Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.

Angela M Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.